Accordingly, to more effectively forecast the occurrence of HT in CIS patients after ITT in clinical practice, this study analyzed the predictive value of Apelin and Vaspin in forecasting it, so as to offer effective reference to future prevention of HT. This evidence concerns the gene SERPINA12 and in situ carcinoma.